According to BioLineRx's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.20. At the end of 2024 the company had a P/S ratio of 2.36.
Year | P/S ratio | Change |
---|---|---|
2024 | 2.36 | -89.64% |
2023 | 22.7 | |
2022 | N/A | |
2021 | N/A | |
2020 | N/A | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A | |
2012 | N/A | |
2011 | N/A |